This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

A study shows the MIND diet had a stronger predictive effect on cognitive decline in Black trial participants compared to ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

People in the U.S. die the youngest and experience the most avoidable deaths, despite spending much more on health care. NBC ...

Breastfeeding through the first year of infants' lives can lower their risk of asthma by colonizing their bodies with a ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) otorgó el martes la aprobación al uso de ribociclib adyuvante (Kisqali) en combinación con un inhibidor de la aromatasa, destinado ...